Skip to main content
Clinical Trials/CTRI/2022/02/040541
CTRI/2022/02/040541Not yet recruitingPhase 3

Efficacy of Indrayavadi Yoga and Shatavari Taila Matrabasti in the Management of Asrigdara (Abnormal Uterine Bleeding): An Open Labelled Single Arm Clinical Trial

institute of teaching and research in ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Both married and unmarried womens having classical features of asrigdara between age group 18-45 years.
  • Patient presenting with any one of the classical features will be included in study.

Exclusion Criteria

  • age below 18 and above 45 years, bleeding due to cervical erosion, carcinoma, fibroids and polyp, bleeding following abortion, bleeding from any site other than uterus, blood coagulation disorders,post menopausal bleeding , hb <7gm%

Investigators

Sponsor
institute of teaching and research in ayurveda

Similar Trials